Format

Send to

Choose Destination
Haematologica. 2019 Aug;104(8):e345-e348. doi: 10.3324/haematol.2018.205302. Epub 2019 Feb 21.

TP53 immunohistochemistry correlates with TP53 mutation status and clearance in decitabine-treated patients with myeloid malignancies.

Author information

1
Department of Pathology and Immunology.
2
Division of Oncology, Department of Internal Medicine, Washington University School of Medicine, St. Louis, MO, USA jwelch@wustl.edu.

Supplemental Content

Full text links

Icon for HighWire Icon for PubMed Central
Loading ...
Support Center